Showing results (341-350 of 397) with videos related to

Sort By:
Pageof 40
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 30, 2018
Factors influencing longitudinal changes of circulating liver enzyme concentrations in subjects randomized to placebo in four clinical trialsDerek J Nunez, Myriam Alexander, Laura Yerges-Armstrong, et al.
Diabetes Care|January 15, 2021
Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET CohortEleni Rebelos, Marco Bucci, Tomi Karjalainen, et al.
Gastroenterology|August 6, 2010
Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individualsPatricia Iozzo, Marco Bucci, Anne Roivainen, et al.
Gastroenterology|January 30, 2007
Quantification of liver glucose metabolism by positron emission tomography: validation study in pigsPatricia Iozzo, Mikko J Jarvisalo, Jan Kiss, et al.
Nature Reviews. Disease Primers|May 19, 2016
Type 2 diabetes mellitusRalph A DeFronzo, Ele Ferrannini, Leif Groop, et al.
Diabetes Care|May 25, 2013
Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert ForumItamar Raz, Matthew C Riddle, Julio Rosenstock, et al.
Lupus Science & Medicine|July 23, 2024
When is the right time to change therapy? An observational study of the time to response to immunosuppressive drugs in systemic lupus erythematosusChiara Tani, Michele Maffi, Giancarlo Cascarano, et al.
Cell Metabolism|June 28, 2016
Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin ResistanceSunjae Lee, Cheng Zhang, Murat Kilicarslan, et al.
Diabetes Care|June 28, 2024
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography StudyAino Latva-Rasku, Eleni Rebelos, Jouni Tuisku, et al.
Heart (British Cardiac Society)|June 5, 2026
Changes in the metabolome after treatment with canagliflozin in patients with type 2 diabetesCraig Peter Coorey, Owen Tang, Mengbo Li, et al.
Pageof 40